Chairman Tang Weikun of the board of directors increased his holdings of Yuanda Pharmaceutical (00512.HK) by 50,000 shares at a price of 8.28 Hong Kong dollars per share.

According to the Wise Finance and Economics APP, the latest information from the Hong Kong stock exchange shows that on November 18, the chairman of the board, Tang Weikun, increased his holdings of Uni-Bio Science Group (00512.HK) by 50,000 shares at a price of HK$8.28 per share, with a total amount of HK$414,000. After the increase, the latest number of shares held is 1 million shares, and the latest shareholding ratio is 0.03%.